- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01747785
Myocardial Performance at Rest and During Exercise in Heart Failure With Preserved Ejection Fraction (X-HF-SPECKLE)
May 13, 2016 updated by: Hector R. Villarraga, M.D., Mayo Clinic
Myocardial Performance at Rest and During Exercise in Heart Failure With Preserved Ejection Fraction: Speckle Tracking Echocardiography - One Piece of the Puzzle.
This study is being done to study how well the heart contracts and relaxes during exercise.
In addition to traditional measures of heart function, we will use a new computer program that may improve understanding of why people feel shortness of breath or fatigue.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
Heart failure with preserved ejection fraction is not well understood, although account for nearly half of all heart failure cases.
This study aims to collect data about systolic (contracting portion of a heart beat) and diastolic (relaxing portion of a heart beat) dysfunction at rest and during exercise.
Participants with normal cardiac function will serve as a control group and compared to participants who are at risk of heart failure.
Study Type
Observational
Enrollment (Actual)
21
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Wisconsin
-
La Crosse, Wisconsin, United States, 54601
- Mayo Clinic Health System - Franciscan Healthcare
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Community sample
Description
Inclusion Criteria:
- 18 years of age or older,
- able to exercise on a bicycle
Exclusion Criteria:
- heart arrhythmias,
- severe chronic obstructive pulmonary disease,
- congenital heart abnormalities,
- infiltrative or hypertrophic cardiomyopathy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Healthy controls
Individuals without history of cardiovascular disease and at least 18 years of age will take a baseline (at rest) cardiopulmonary exercise test (CPX) and have a cardiac echocardiogram to measure myocardial deformation.
CPX and echocardiograms will be repeated during exercise sessions at 3 visits over a 12 week period.
|
A 2D Doppler echocardiograph (image) of the heart will be captured during a single heart beat taken at rest and during cardiopulmonary exercise tests to measure left and right ventricular segmental systolic and diastolic strain measurements.
The cardiopulmonary exercise test consists of cycling exercise of mild and moderate intensity on an upright cycle ergometer on a tilting table (to facilitate imaging) for 6-10 minute periods within a one hour session.
|
|
Patients at risk of heart failure
Individuals at risk of heart failure and a preserved ejection fraction of at least 50% will take a baseline (at rest) cardiopulmonary exercise test (CPX) and have a baseline cardiac echocardiogram to measure myocardial deformation.
CPX and echocardiograms will be repeated during exercise sessions at 6 visits over a 12 week period.
A cardiac rehabilitation exercise program will also occur over 12 weeks.
|
A 2D Doppler echocardiograph (image) of the heart will be captured during a single heart beat taken at rest and during cardiopulmonary exercise tests to measure left and right ventricular segmental systolic and diastolic strain measurements.
The cardiopulmonary exercise test consists of cycling exercise of mild and moderate intensity on an upright cycle ergometer on a tilting table (to facilitate imaging) for 6-10 minute periods within a one hour session.
Aerobic cardiac exercise training will be provided over the 12 week study duration.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in mean cardiac reserve as measured by strain rate
Time Frame: Baseline, 12 weeks
|
Myocardial deformation imaging (e.g.
strain, strain rate, torsion) requires clear 2-dimensional echocardiography images that will be obtain at rest and during mild and moderate intensity exercise.
Images will be captured during 6-10 minute bouts of exercise on a tilting exercise table.
Comparisons will be made on resting and exercise values between groups.
Our hypothesis is that strain rate will not increase in patients at risk of heart failure demonstrating lack of cardiovascular reserve.
|
Baseline, 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in mean cardiac stroke volume
Time Frame: Baseline, 12 weeks
|
Stroke volume is the volume of blood (in milliliters) ejected during each heart contraction, It is measured by combined Doppler and 2-dimensional echocardiography.
A surrogate measure of stroke volume (oxygen-pulse) can also be obtained during cardiopulmonary exercise testing by dividing the measured oxygen consumption by the heart rate.
Our hypothesis is that stroke volume will plateau early after exercise onset in patients at risk of heart failure and this plateau will correlate with a reduction in strain rate.
|
Baseline, 12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Hector Villarraga, MD, Mayo Clinic
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2012
Primary Completion (Actual)
July 1, 2015
Study Completion (Actual)
July 1, 2015
Study Registration Dates
First Submitted
December 7, 2012
First Submitted That Met QC Criteria
December 10, 2012
First Posted (Estimate)
December 12, 2012
Study Record Updates
Last Update Posted (Estimate)
May 17, 2016
Last Update Submitted That Met QC Criteria
May 13, 2016
Last Verified
January 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 12-005553
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
Indiana UniversityRecruitingCongestive Heart Failure | Congestive Heart Failure (CHF) | Congestive Heart Failure Chronic | Congestive Heart Failure(CHF)United States
-
University of Health Sciences LahoreRecruitingAcute Decompensated Heart Failure | Heart Failure, Diastolic | Heart Failure, SystolicPakistan
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
Lakeland Regional Health Systems, Inc.RecruitingHeart Failure | Heart Failure Acute | Acute Heart Failure (AHF) | Heart Failure - NYHA II - IVUnited States
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
Eli Lilly and CompanyNot yet recruitingHeart Failure | Heart Failure, Diastolic | Heart Failure, SystolicUnited States, Japan
-
Wake Forest UniversityCompletedHeart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
Clinical Trials on Myocardial deformation imaging
-
RWTH Aachen UniversityCompletedMyocardial Viability in Ischemic Left Ventricular Dysfunction | Prediction for Improvement in Cardiac Function After Revascularization TherapyGermany
-
RWTH Aachen UniversityCompleted
-
University Hospital of WalesHull University Teaching Hospitals NHS Trust; Danderyd Hospital; Universitat... and other collaboratorsUnknownIschemia, MyocardialBelgium, Sweden, United Kingdom
-
University Hospital, BordeauxCompletedLeukemia | Cardiac ToxicityFrance
-
China National Center for Cardiovascular DiseasesNot yet recruiting
-
Kartal Kosuyolu Yuksek Ihtisas Education and Research...University of Rome Tor Vergata; San Raffaele University Hospital, ItalyRecruitingCoronary Artery Bypass | Heart Valve Diseases | Cardiopulmonary Bypass | Intraoperative Complications | Echocardiography | Postoperative Complications (Cardiopulmonary)Italy, Turkey (Türkiye)
-
National Heart Centre SingaporeNational Medical Research Council (NMRC), SingaporeRecruitingCoronary Artery Disease | Diabetes MellitusSingapore
-
Aspire FoundationBlue Cross Blue Shield; Saint Luke's Cardiovascular Consultants; Cardiovascular... and other collaboratorsCompletedCoronary Artery DiseaseUnited States
-
St. Louis UniversityAstellas Pharma US, Inc.WithdrawnCoronary Artery DiseaseUnited States
-
Sinotau Pharmaceutical GroupRecruitingHeart Failure | Ischemic CardiomyopathyChina